Skip to content

Clinical trials

Observational Atrial Fibrillation trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Observational Country / region: China Clear all

110 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20092
20113
20123
20134
20142
20154
20167
20176
20184
20196
20203
20217
202214
20236
202418
202515
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34
Unknown status30
Recruiting27
Not yet recruiting10
Active, not recruiting5
Enrolling by invitation3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital10
Shanghai 10th People's Hospital6
Second Affiliated Hospital, Zhejiang University, School of Medicine5
China National Center for Cardiovascular Diseases4
Chinese Academy of Medical Sciences, Fuwai Hospital4
Boston Scientific Corporation3
First Affiliated Hospital Xi'an Jiaotong University3
The University of Hong Kong3
Xijing Hospital3
Abbott Medical Devices2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation110
Stroke12
Heart Failure7
Ischemic Stroke6
Embolic Stroke4
Heart Valve Diseases4
Myocardial Infarction4
Coronary Disease3
Arrhythmias, Cardiac2
Atrial Flutter2

Trials

Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.

10 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.